newsfilter
← Latest News
GlobeNewswire·

Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants

CUPERTINO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet